Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients

Post navigation

Identification of deletion-duplication in HEXA gene in five children with Tay-Sachs disease from India

A cancer vaccine approach for personalized treatment of Lynch Syndrome

Signios Biosciences:
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

Registered Office:
MedGenome Inc. 108 West 13th Street Wilmington, Delaware 19801, County of New Castle, USA

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.